Avantax Planning Partners, Inc. Teva Pharmaceutical Industries LTD Transaction History

Avantax Planning Partners, Inc.

  • $2.78 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$14.59 - $23.84 $12,561 - $20,526
-861 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$21.06 - $25.65 $18,132 - $22,084
861 New
861 $19,000
Q2 2018

Aug 13, 2018
SELL
$16.77 - $24.71 $14,438 - $21,275
-861 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$16.68 - $22.07 $14,361 - $19,002
861 New
861 $15,000

Others Institutions Holding TEVA

# of Institutions
640
Shares Held
580M
Call Options Held
19.6M
Put Options Held
6.77M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.1B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Avantax Planning Partners, Inc. Portfolio

Follow Avantax Planning Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Planning Partners, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email